As of Mar 22
| -0.96 / -4.94%|
The 19 analysts offering 12-month price forecasts for ACADIA Pharmaceuticals Inc have a median target of 21.00, with a high estimate of 33.00 and a low estimate of 12.00. The median estimate represents a +13.57% increase from the last price of 18.49.
The current consensus among 21 polled investment analysts is to Hold stock in ACADIA Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.